Company Filing History:
Years Active: 2001
Title: The Innovations of Christer Betsholtz
Introduction
Christer Betsholtz is a notable inventor based in Frolunda, Sweden. He has made significant contributions to the field of biomedical research, particularly in the area of transgenic animals. His work focuses on the vascular endothelial growth factor B (VEGF-B), which plays a crucial role in various biological processes.
Latest Patents
Christer Betsholtz holds a patent for a transgenic animal with recombinant vascular endothelial growth factor B (VEGF-B DNA) and its uses. This patent involves transgenic animals containing recombinant DNA with a modified nucleotide sequence from the VEGF-B gene. The patent also covers methods for producing such animals and their application in assaying substances for VEGF-B-like activity. He has 1 patent to his name.
Career Highlights
Betsholtz is associated with the Ludwig Institute for Cancer Research Limited, where he continues to advance his research. His work has implications for understanding cancer biology and developing new therapeutic strategies.
Collaborations
He has collaborated with notable colleagues, including Gabriel Von Euler and Karin Aase, contributing to a rich environment of scientific inquiry and innovation.
Conclusion
Christer Betsholtz's work exemplifies the intersection of innovation and research in the field of biomedical science. His contributions, particularly in the development of transgenic animals, are paving the way for future advancements in understanding and treating diseases.